FamiCord Group member wins the second editon of Strategmed
24 February 2007 FamiCord member company won the second edition of the strategic “Prevention and treatment of diseases of civilization” – STRATEGMED Consortium Circulate which includes Polski Bank Komórek Macierzystych (Polish Stem Cell Bank), Jagiellonian University, and many other renowned research centers won the second edition of the program organized by the National Centre for Research […]
FamiCord Group opened a new laboratory in Budapest
KRIO Institute in Hungary opened a new laboratory to enable the stem cell bank to process samples manually. Manual technology allows for the correction of errors that may occur during collection and separation of blood, thus samples made available for a future therapy are especially rich in cells. Manual procedure Cord blood must be processed within 36 […]
High proportion of VSEL cells in samples stored in FamiCord Group
The processing procedure KRIO Institute applies, enables an especially large number of VSEL cells to survive. VSEL cells are present in a much larger proportion in the final preparation process than in the unprocessed umbilical cord blood. VSEL cells tolerate freezing very well, as shown in samples stored at KRIO which are rich in VSEL […]
Krio Institute (FamiCord Group) is to patent new stem cell processing method
KRIO has submitted an application to the Hungarian Intellectual Property Office to patent a new method for processing and storing mesenchymal stem cells (MSCs). MSCs are stem cells present in the umbilical cord connective tissue. The significance of the new and unique method is that it enables physicians to isolate more stem cells in a better condition […]
FamiCord Group continues international expansion
Yasam is the oldest Turkish stem cell bank and has been operating for over 10 years. Yasam, like all FamiCord Group banks, has the highest quality standards. By 2013, it had provided on 4 occasions deposited umbilical cord blood to treat children. Yasam has its own specialized laboratory, providing the highest standards of quality class […]
Sevibe Cells- the only bank in Spain accredited with AABB
In October 2015 Sevibe Cells became the first bank in Spain accredited by the American Association of Blood Banks (AABB) – internationally recognized symbol of quality of products and services in the filed of cord blood banking. Being accredited by AABB means that all Clients of Sevibe Cells can be sure that we meet the highest […]
PBKM becomes a member of EBMT
We are very proud to report that Polski Bank Komórek Macierzystych has become a member of EBMT – European Society for Blood and Marrow Transplantation. It is the biggest non-profit organization in the world which brings together scientists, doctors and nurses engaged in research on clinical use of stem cells from different sources, including cells from […]
PBKM granted 13.7 mln PLN funds from NCBiR
The National Center for Research and Development (NCBiR) in Poland accepted request of PBKM for co-financing of the project “Development of an innovative advanced therapy medicinal product based on mesenchymal cells derrived from of the Wharton jelly in treatment of amyotrophic lateral sclerosis”. Funding granted for this project is in the amount of approx. 13.7 […]
Expansion of Famicord activity to Balkans
BioSave becomes a FamiCord Group partner in Balkan countries, i.e on the territory of Serbia, Bosnia and Herzegovina, Montenegro, Albania, Slovenia, Macedonia and Croatia.
Acquisition of BioCell Lugano, Switzerland
FamiCord Group acquired BioCell Lugano with a modern laboratory in Switzerland. This is another important step towards expanding the scope of activities in Europe.
